-
Mylan seeks approval for generic fibromyalgia drug
PITTSBURGH — Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.
Mylan said Wednesday that Forest Labs and Royalty Pharma had sued it in the U.S. District Court for the District of Delaware in connection with its filing of a regulatory approval application with the Food and Drug Administration for milnacipran hydrochloride tablets in the 12.5-mg, 25-mg, 50-mg and 100-mg strengths. The drug is a generic version of Savella.
-
Popcorn, Indiana brings back holiday Drizzlecorn collection
ENGLEWOOD, N.J. — Backed by consumer demand, Popcorn, Indiana, maker of all-natural popcorn snacks, is set to usher in the 2013 holiday season with the return of its Drizzlecorn collection.
The collection features five extraordinary varieties: Dark Fudge Chocolate Chip Kettlecorn, Drizzled Black & White Kettlecorn, Drizzled Cinnamon Sugar Kettlecorn, Chocolate Peanut Butter Kettlecorn, and Dark Fudge Peppermint Kettlecorn. Hitting shelves nationwide for a limited time only, Popcorn, Indiana’s line of flavors will be available starting this October.